Sarepta Therapeutics (SRPT) — Entry Risk Score

Stock · re-scored every trading day · data as of 2026-11-12

88
on a 30–98 scale
BUY
$16.01last close
+12score vs prior day
70–91range since 10-12
-8.2%price since 10-12

The entry score measures one thing: how far Sarepta Therapeutics's price sits from a defensible technical level, on a 30–98 scale. High scores (79+) mean the price has pulled back into a zone where risk can be defined; low scores mean the price is extended above its own trend — not that the stock is bad, but that chasing it here carries undefined risk. The full formula is public on our methodology page.

On 2026-11-12, Sarepta Therapeutics's price sits 2.05 ATR below its 20-day average ($18.00); it trades below its 200-day average ($18.54); its 14-day RSI is 39; it has moved -6.37% over 20 sessions; our regime filter classifies it as no confirmed trend.

Falling-knife flag: this Buy Zone score comes on top of a -16.7% decline over roughly 60 sessions. In our own data that pattern has swung harder than other Buy Zone names in both directions. See the audit.

Is Sarepta Therapeutics (SRPT) a buy right now?

Sarepta Therapeutics scores 88/98 (Buy) as of 2026-11-12; it is 32.8% below its 52-week high of $23.83; it is below its 200-day average; it moved -10.16% over the last 5 sessions. A high score means our model rates today's price as a favorable, defined-risk entry, based on where it sits versus its 20-day average after adjusting for trend and volatility. It is not a prediction that the price will rise. It also carries a falling-knife flag (down 16.7% over ~60 sessions). Not investment advice.

Score history

80 60

Every point is a recorded daily snapshot, committed publicly the evening it was scored — history can't be rewritten after the fact.

DateScoreΔClose
2026-11-1288+12$16.01
2026-11-0676-4$17.82
2026-11-0580+3$17.57
2026-11-0477+7$18.99
2026-11-0370-4$18.54
2026-11-0274-2$18.32
2026-10-2976+4$19.23
2026-10-2872-5$19.32
2026-10-2777+5$18.89
2026-10-2672-5$17.98
2026-10-2377+4$17.73
2026-10-2273-2$18.18

Related stocks

See today's full rankings + entry plan for SRPT →

Get the Sunday Brief

One email a week, before the open: what the board did, which calls worked, which didn't, and what changed. Free. No spam, unsubscribe anytime.